1,244
Views
4
CrossRef citations to date
0
Altmetric
Research Paper

Circular RNA-UBE2D2 accelerates the proliferation and metastasis of non-small cell lung cancer cells via modulating microRNA-376a-3p/Eukaryotic Translation Initiation Factor 4γ2 axis

, , , , , & show all
Pages 5942-5953 | Received 01 Dec 2021, Accepted 04 Jan 2022, Published online: 23 Feb 2022

References

  • Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
  • Di Noia V, D'Argento E, Pilotto S Grizzi G, Caccese M, Iacovelli R, Tortora G, Bria E . Necitumumab in the treatment of non-small-cell lung cancer: clinical controversies. Expert Opin Biol Ther. 2018;18(9):937–945.
  • Balata H, Fong KM, Hendriks LE, et al. Prevention and early detection for NSCLC: advances in thoracic oncology 2018. J Thorac Oncol. 2019;14(9):1513–1527.
  • Reck M, Rabe K, Longo DL. Precision diagnosis and treatment for advanced non-small-cell lung cancer. N Engl J Med. 2017;377(9):849–861.
  • Beermann J, Piccoli M-T, Viereck J, et al. Non-coding RNAs in development and disease: background, mechanisms, and therapeutic approaches. Physiol Rev. 2016;96(4):1297–1325.
  • Saaoud F, Drummer I.V C, Shao Y, et al. Circular RNAs are a novel type of non-coding RNAs in ROS regulation, cardiovascular metabolic inflammations and cancers. Pharmacol Ther. 2021;220:107715.
  • Li C, Zhang L, Meng G, et al. Circular RNAs: pivotal molecular regulators and novel diagnostic and prognostic biomarkers in non-small cell lung cancer. J Cancer Res Clin Oncol. 2019;145(12):2875–2889.
  • Tian F, Yu CT, Ye WD, et al. Cinnamaldehyde induces cell apoptosis mediated by a novel circular RNA hsa_circ_0043256 in non-small cell lung cancer. Biochem Biophys Res Commun. 2017;493(3):1260–1266.
  • Qu D, Yan B, Xin R, et al. A novel circular RNA hsa_circ_0020123 exerts oncogenic properties through suppression of miR-144 in non-small cell lung cancer. Am J Cancer Res. 2018;8(8):1387–1402.
  • Wang Y, Li J, Du C, et al. Upregulated circular RNA circ-UBE2D2 predicts poor prognosis and promotes breast cancer progression by sponging miR-1236 and miR-1287. Transl Oncol. 2019;12(10):1305–1313.
  • Hu K, Liu X, Li Y, et al. Exosomes mediated transfer of Circ_UBE2D2 enhances the resistance of breast cancer to tamoxifen by binding to MiR-200a-3p. Med Sci Monit. 2020;26:e922253.
  • Liao J, Shen J, Leng Q, et al. MicroRNA-based biomarkers for diagnosis of non-small cell lung cancer (NSCLC). Thorac Cancer. 2020;11(3):762–768.
  • Xie F, Li L, Luo Y, et al. Long non-coding RNA LINC00488 facilitates thyroid cancer cell progression through miR-376a-3p/PON2. Biosci Rep. 2021;41(3). DOI:10.1042/BSR20201603.
  • Wang Y, Jiang F, Xiong Y, et al. LncRNA TTN-AS1 sponges miR-376a-3p to promote colorectal cancer progression via upregulating KLF15. Life Sci. 2020;244:116936.
  • Fellenberg J, Lehner B, Saehr H, et al. Tumor suppressor function of miR-127-3p and miR-376a-3p in osteosarcoma cells. Cancers (Basel). 2019;11(12):2019.
  • Chen L, Jing S-Y, Liu N, et al. MiR-376a-3p alleviates the development of glioma through negatively regulating KLF15. Eur Rev Med Pharmacol Sci. 2020;24(22):11666–11674.
  • Lewis S, Cerquozzi S, Graber TE, et al. The eIF4G homolog DAP5/p97 supports the translation of select mRNAs during endoplasmic reticulum stress. Nucleic Acids Res. 2008;36(1):168–178.
  • Nousch M, Reed V, Bryson-Richardson RJ, et al. The eIF4G-homolog p97 can activate translation independent of caspase cleavage. RNA. 2007;13(3):374–384.
  • Warnakulasuriyarachchi D, Cerquozzi S, Cheung HH, et al. Translational induction of the inhibitor of apoptosis protein HIAP2 during endoplasmic reticulum stress attenuates cell death and is mediated via an inducible internal ribosome entry site element. J Biol Chem. 2004;279(17):17148–17157.
  • Emmrich S, Engeland F, El-Khatib M, et al. miR-139-5p controls translation in myeloid leukemia through EIF4G2. Oncogene. 2016;35(14):1822–1831.
  • Mazan-Mamczarz K, Zhao XF, Dai B, et al. Down-regulation of eIF4GII by miR-520c-3p represses diffuse large B cell lymphoma development. PLoS Genet. 2014;10(1):e1004105.
  • Xie X, Li Y-S, Xiao W-F, et al. MicroRNA-379 inhibits the proliferation, migration and invasion of human osteosarcoma cells by targeting EIF4G2. Biosci Rep. 2017;37(3). DOI:10.1042/BSR20160542.
  • Lei K, Bai H, Wei Z, et al. The mechanism and function of circular RNAs in human diseases. Exp Cell Res. 2018;368(2):147–158.
  • Travis W, Brambilla E, Burke AP, et al. Introduction to the 2015 World Health Organization classification of tumors of the lung, pleura, thymus, and heart. J Thorac Oncol. 2015;10(9):1240–1242.
  • Liu Q, Cao G, Wan Y, et al. Hsa_circ_0001073 targets miR-626/LIFR axis to inhibit lung cancer progression. Environ Toxicol. 2021;36(6):1052–1060.
  • Yuan Y, Zhou X, Kang Y, et al. Circ-CCS is identified as a cancer-promoting circRNA in lung cancer partly by regulating the miR-383/E2F7 axis. Life Sci. 2021;267:118955.
  • Kulcheski F, Christoff A, Margis R. Circular RNAs are miRNA sponges and can be used as a new class of biomarker. J Biotechnol. 2016;238:42–51.
  • Wan J, Hao L, Zheng X, Zheng, L . Circular RNA circ_0020123 promotes non-small cell lung cancer progression by acting as a ceRNA for miR-488-3p to regulate ADAM9 expression. Biochem Biophys Res Commun. 2019;515(2):303–309.
  • Weingarten-Gabbay S, Khan D, Liberman N, et al. The translation initiation factor DAP5 promotes IRES-driven translation of p53 mRNA. Oncogene. 2014;33(5):611–618.
  • de La Parra C, Ernlund A, Alard A, et al. A widespread alternate form of cap-dependent mRNA translation initiation. Nat Commun. 2018;9(1):3068.
  • Bellsolell L, Cho-Park PF, Poulin F, et al. Two structurally atypical HEAT domains in the C-terminal portion of human eIF4G support binding to eIF4A and Mnk1. Structure. 2006;14(5):913–923.
  • Marash L, Liberman N, Henis-Korenblit S, et al. DAP5 promotes cap-independent translation of Bcl-2 and CDK1 to facilitate cell survival during mitosis. Mol Cell. 2008;30(4):447–459.
  • Hundsdoerfer P, Thoma C, and Hentze M. Eukaryotic translation initiation factor 4GI and p97 promote cellular internal ribosome entry sequence-driven translation. Proceedings of the National Academy of Sciences of the United States of America, Communicated by Jennifer A. Doudna, University of California, Berkeley, CA, 2005. 102( 38): p. 13421–13426.
  • Zhao H, Wang A, Zhang Z. LncRNA SDHAP1 confers paclitaxel resistance of ovarian cancer by regulating EIF4G2 expression via miR-4465. J Biochem. 2020;168(2):171–181.
  • Hao G, Hao H-J, Ding Y-H, et al. Suppression of EIF4G2 by miR-379 potentiates the cisplatin chemosensitivity in nonsmall cell lung cancer cells. FEBS Lett. 2017;591(4):636–645.